ストックスクリーナーアプリを入手
1,043.29
0.60%
-6.31
プレマーケット:
1040.51
-2.78
-0.27%
Lilly Eli Co (LLY) 最新ニュース
Evaluating Eli Lilly Shares After 30% Surge Driven by Obesity Drug Pipeline News - Yahoo Finance
Eli Lilly & Co. is opening a Lilly Gateway Labs biotech incubator in Philadelphia - The Daily Gazette
Eli Lilly Enters Uncharted Territory as Market Cap Nears $1T - BioSpace
Is Pfizer's 6.9%-Yielding Dividend Still Safe? - The Motley Fool
A “human” approach to healthcare - Fast Company
Beyond GLP-1: Eli Lilly's Expanding Drug Portfolio Lifts Sales - Nasdaq
Pfizer exec challenges Novo Nordisk, Eli Lilly after Metsera win - medwatch.com
Novo Nordisk Just Made a Big Move in the Weight Loss Drug Market. Should You Worry About Rival Eli Lilly? - Yahoo Finance
Eli Lilly Expands Innovation Network with Strategic Philadelphia Hub - Ad-hoc-news.de
ABLBio (298380 KS): Funding From Lilly To Strengthen Drug Development Capabilities - Smartkarma
News | Drugmaker Eli Lilly to open shared lab space for fledgling biotech startups in Philadelphia - CoStar
Eli Lilly Startup Incubator Coming To Market West: The Philadelphia Deal Sheet (November 19, 2025) - Bisnow
Owner Lilly Endowment Inc Sells 60,213 ($62.3M) Of Eli Lilly & Co [LLY] - TradingView
Owner Lilly Endowment Inc Files To Sell 310,000 Of Eli Lilly & Co [LLY] - TradingView
Eli Lilly To Rally More Than 12%? Here Are 10 Top Analyst Forecasts For Wednesday - inkl
Truist Securities Raises Price Target for Eli Lilly (LLY) to $11 - GuruFocus
Will Eli Lilly Stock (LLY) Split? Rumors Are Swirling. - TipRanks
Lilly to open Gateway Labs site in Philadelphia - Inside INdiana Business
Truist Raises Price Target on Eli Lilly to $1,182 From $1,038, Keeps Buy Rating - MarketScreener
Philadelphia Selected for New Lilly Gateway Labs at Breakthrough Properties – 2300 Market Street - BioBuzz
Celltrion to widen US manufacturing reach with $478M investment at former Lilly plant - Fierce Pharma
Eli Lilly (LLY) Expands Biotech Incubator to Philadelphia - GuruFocus
Eli Lilly on "Stock Split Watch": A Deep Dive into a Pharmaceutical Giant's Future - FinancialContent
Lilly to Open Lilly Gateway Labs Site in Philadelphia - Contract Pharma
EXPLORING THE GLOBAL TRANSFORMATION OF HEALTH CARE WITH ELI LILLY's CEO DAVE RICKS - StreetInsider
T. Rowe Price (NASDAQ: TROW) features Eli Lilly CEO on 'The Angle' health care episode - Stock Titan
Eli Lilly Unusual Options Activity For November 19 - Benzinga
Eli Lilly Stock Gains Momentum on Medicare Deal and Optimistic Outlook - AskTraders.com
Lilly Announces Plans To Open Lilly Gateway Labs Site In Philadelphia - citybiz
Eli Lilly wants to be part of making a big dent in obesity and diabetes, says co's India head Winselow Tuc - The Economic Times
Truist Raises Price Target on Eli Lilly to $1,182 From $$1,038, Keeps Buy Rating - MarketScreener
The Weight-Loss Craze Is About to Mint a Trillion-Dollar Company - MSN
Eli Lilly (LLY) Announces New Gateway Labs Site in Philadelphia - GuruFocus
Morning Business Report: Rising homeownership costs, Eli Lilly’s surge, and NVIDIA earnings - 41NBC News
Eli Lilly price soarsForecast today19-11-2025 - Economies.com
Truist Securities raises Eli Lilly stock price target to $1,182 on obesity drug outlook - Investing.com India
Lilly to open new Gateway Labs site in Philadelphia By Investing.com - Investing.com South Africa
Lilly to open new Gateway Labs site in Philadelphia - Investing.com
Breakthrough and Lilly partner on new biotech lab space in Philadelphia - Investing.com
'At the top of our game': Lilly picks Philadelphia as next spot for early-stage biotech lab space - Fierce Biotech
Eli Lilly picks Market Street building for its Philadelphia Gateway Labs innovation hub - The Business Journals
Eli Lilly Gains from Big Earnings, Bullish Inflows - FXEmpire
Missed Out on Eli Lilly? 2 Healthcare Stocks With Big Catalysts on the Horizon. - AOL.com
Eli Lilly, Fluor celebrate veterans - reporter.net
The Zacks Analyst Blog Highlights Microsoft, Amazon.com and Eli Lilly - Nasdaq
Eli Lilly (LLY) Poised to Become First Trillion-Dollar Pharma Co - GuruFocus
Eli Lilly Shares Surge as JPMorgan Raises Price Target to $1,150 - Ad-hoc-news.de
Major Shareholder Sells Millions in Eli Lilly Stock! - TipRanks
Eli Lilly and Co(LLY.US) 10% Shareholder Sells US$10.19 Million in Common Stock - 富途牛牛
Is Eli Lilly and Company stock positioned for secular growth2025 Trading Volume Trends & Fast Moving Trade Plans - newser.com
Top Research Reports for Microsoft, Amazon.com & Eli Lilly - Nasdaq
Novo Nordisk, Eli Lilly Weight Loss Price War Heats Up. Why It’s a Worry for the Stocks. - Barron's
Senator questions Lilly CEO on details of Trump deal for weight loss drugs - Endpoints News
Gallego demands answers on Eli Lilly’s deal with Trump - The Hill
Novo Nordisk (NVO) and Eli Lilly (LLY) Cut Drug Prices to Enhance U.S. Accessibility - Somos Hermanos -
ABL Bio Enters $2.6 Billion Multi-Program Collaboration Agreement with Eli Lilly - PharmExec.com
Eli Lilly Upgraded, Chewy Downgraded: Updated Rankings on Top Blue-Chip Stocks - InvestorPlace
Lilly to participate in Citi's 2025 Global Healthcare Conference - Investing News Network
JPMorgan raises Eli Lilly stock price target to $1,150 on obesity drug outlook - Investing.com Canada
Eli Lilly's (LLY) Donanemab Gains Approval in India - GuruFocus
Jim Cramer Comments On Eli Lilly (LLY)’s Shares After Pfizer CEO’s Remarks - MSN
Global drugmakers rush to boost US presence as tariff threat looms - Reuters
JPMorgan Adjusts PT on Eli Lilly and Co. to $1,150 From $1,050, Maintains Overweight Rating - MarketScreener
TD Cowen Maintains Buy on Eli Lilly (LLY) After Government Deal - MSN
0.28%
1.49%
大文字化:
|
ボリューム (24 時間):